Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Related CRL
Charles River Laboratories, AstraZeneca Renew Strategic Partnership Agreement
Benzinga's Top Downgrades

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A


Related Articles (CRL)

Get Benzinga's Newsletters